Search

everythinglearnresearchcommunity

for

Search:↓

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Low iron levels are linked to hair loss in women.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Androgenetic alopecia is significantly linked to metabolic syndrome.

The treatment might help COVID-19 related hair loss, but more research is needed.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

High-frequency ultrasound can effectively visualize and assess hair loss.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.

PRP improves hair transplant results in androgenetic alopecia patients.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.